Mrs. Laurien Aben

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ahmed Mohammed AboAbat, BScPT, MHA, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Shannon Corinne Achille

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Miss Sabrina Agnihotri

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Nadine Akbar, M.Sc., Ph.D. Candidate

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Gilles Allali, M.D./Ph.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

We do not use unlabeled/unapproved drugs or products in our research

Derrick Brett Allred, M.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Fabrisia Ambrosio, PhD, MPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Nicole Anderson, PhD, CPsych

Participant discloses the following relationships:

1. Living with mild cognitive impairment: A guide to maximizing brain health and reducing risk of dementia:

Author

2. Learning the Ropes: IP holder

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Elizabeth A. Apple, PMP, MBA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Amir Massoud Arab, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. David B. Arciniegas, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will be discussing acetylcholineresterase inhibitors for brain injury-related cognitive impairments; use of this

class of medications for this purpose is "off label.'

Harriet Udin Aronow, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Arash Asher, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Diane Atkins, OTR

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Gunnbjørg Aune, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Arash Babaei-Ghazani, M.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Suzanne Babyar, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Samantha Backhaus, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Deborah Backus, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Lu Bai, BEng

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Julie Baker, M.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Chitra Balasubramanian

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Martha C Banda, PhD (Rehabilitation); MSMedSc (R

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gerard A Banez, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Brenda Banwell, MD

Participant discloses the following relationships:

1. Biogen-IDEC: Consultant

2. Sanofi: Consultant

3. Novartis: Consultant

4. Teva Neuroscience: Consultant

5. Multiple Sclerosis and Related Disorders: Editor-in-Chief

Participant has indicated the following discussion of unapproved drug or product uses:

off-label therapies for MS

Dr Jeffrey R Basford, MD PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Kerry Nicole Bayless, P.T.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mark Theodore Bayley, MD, FRCPC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jonathan Bean, MD, MS, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Marla Beauchamp, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Cynthia L Beaulieu, PhD, ABPP-CN

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Louis-David Beaulieu, MSc, PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Simon Beaulieu-Bonneau

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Kathleen Reilly Bell, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Barbara Bendlin, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Thomas F. Bergquist, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Hilary Bertisch

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Sara Bertoch, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dhruti Bhandari

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

C. Scott Bickel, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Samuel Michael Bierner, MD, MRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Saad M Bindawas, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sonja Blum

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Helena Blumen, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Marcie Bockbrader, MD PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Wendy Boerboom

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

not applicable

Dr. Yelena Bogdanova, PhD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jamie M Bogle, AuD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jennifer Bogner, PhD, ABPP, FACRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Chuck Bombardier, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Carolina Bottari, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Amanda L. Botticello, PhD, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Chris Boulias, M.D., Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Laura Brach, PT, DPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jacquie Brown, MES, RSW

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Tania Rosaria bruno, MD, FRCPC, CSCN (Dip) EMG

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Blake Burdett, E.S.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Anthony Scott Burns, MD, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Tamara Bushnik, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jaap Buurke, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Julie Cagney, PT, DPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Claire Cahow, CTRS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Xinsheng Cai, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jill I. Cameron, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Michelle Cameron, M.D., P.T.

Participant discloses the following relationships:

1. Acorda Therapeutics: Consultant

2. National Multiple Sclerosis Society: Grant Funding

3. Multiple Sclerosis International Federation: Grant Funding

4. Collins Medical Trust: Grant Funding

5. Department of Veterans Affairs Rehabilitation Research and Development Service: Grant Funding

Participant has indicated no discussion of unapproved drug or product uses.

Dr Grace Campbell, PhD, MSW, CRRN

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Yue Cao, PhD, MSPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Tereza Cristina Carbonari de Faria

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Francesco Carli, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Noelle Carlozzi

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr James Jeffrey Carollo, PhD, PE

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Simon Carson, OT/L, MBA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Michael Paul Cary, Jr., RN

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. J. David Cassidy, PhD, DrMedSci

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Anne H. Chan, PT, DPT, MBA, NCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Leighton Chan, MD MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Vincy Chan, MPH, PhD Candidate

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Eugene Chang, M.D., F.R.C.P.C.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Feng-Hang Chang, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Kwang-Hwa Chang, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Susan Charlifue, PhD, FACRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Camille Chatelle, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Oren Cheifetz, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Christine C Chen, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Chun-Chuan Chen

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Cynthia Chen, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Peii Chen, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Yuying Chen, MD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Andrea L Cheville, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Wen-Chou Chi

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Nancy D. Chiaravalloti, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Yu-Pei Chien, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Winnie Szu Yun Chin, B.S.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ming-Chun Choi

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Michael Choo, MD MBA CIME FACEP FAAEM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lin-Chuan Chou

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Willy Chou, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Julie Chi Chow, M D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Christine Chung

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Angela Ciccia, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Eduardo NMN Cisneros, M.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Anne Schnepf Citorik, MS, CCC-SLP, CBIS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ismari Clesson, RN

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Angela Colantonio, PhD, FACRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Rita Cole, PT, DPT

Disclosure has not been provided.

Ms Heather E Coles, M.A. CCC-SLP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Paul Comper, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Fofi Constantinidou, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Cynthia Cooper, MA, OTR, CHT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

John D. Corrigan, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. John D. Corrigan, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Rachel Cowan, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr B. Catharine Craven, BA, MD, FRCPC, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

WBV platforms, Extension of ISCD guidelines

Dr Adrian Cristian, MD

Participant discloses the following relationships:

1. Demos Medical Publishers: Royalties for books

Participant has indicated no discussion of unapproved drug or product uses.

Mr Lucas D Crosby

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Barbara Csenge, BA, B.Ed

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jeffrey P. Cuthbert, PhD, MPH, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs, Joan Cutillo, LPN,CCRC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

We may discuss research that is done for different indications, what TYPES of meds are being studied, what

TYPES of procedures are being studied, without naming any medication or study specifically. We may only

describe the action of the medication or device and what indication it is treating on the study. No proprietary

information will be given out.

Suzanne Daghstani, MS, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Marie N Dahdah, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Piyapat Dajpratham, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Toril Dale

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Kristen Dams-O'Connor, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Ellen Kathleen Danford, BA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Claire Davies, PEng.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Drew Davis, MD

Participant discloses the following relationships:

1. NIH: Co-investigator

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Deirdre Dawson, PhD, OT Reg (Ont.)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Christina May Moran de Brito, MD PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Janet Marie Dean, MS, RN, CRRN, CPNP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Raisa Berlin Deber, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

This particular statement does not apply to me

Gerben DeJong, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Jude J. Delparte, M.Sc.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Thierry Deltombe, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. John Deluca, PhD

Participant discloses the following relationships:

1. Biogen, Idec: Consultant; Grant Funding

2. Novartis Pharmaceuticals Corporation: Consultant

3. National Hockey League/Major League Soccer: Consultant

4. EMD Serono: Speaker's Bureau

Participant has indicated no discussion of unapproved drug or product uses.

Dr Stephanie C DeLuca, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Carol Ann DeMatteo, OT MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Vincent DePaul, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Anne Deutsch, RN, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Ayan K. Dey, BSc.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

N/A

Dr Christina (Tina) Dillahunt-Aspillaga, PhD, CRC, CVE, CLCP, PVE, CBIST

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Stephanie DiPoce

Disclosure has not been provided.

Ms. Margaret A DiVita, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Ekaterina Dobryakova

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Matthew James Doiron

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lianne B Dolan, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. James Donovan, DC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

ms Nancy Dukelow, MS, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Kari Dunning, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Tilak Dutta

Disclosure has not been provided.

Brenda Eagan Brown, MEd., CBIS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Victor Reggie Edgerton, Ph.D.

Participant discloses the following relationships:

1. NeuroRecovery Technologies: Chairman and Member of the Board

Participant has indicated the following discussion of unapproved drug or product uses:

Will be discussing non-FDA approved transcutaneous stimulators.

Dr Dylan Edwards, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

TMS and TDCS

Ms Parvin Eftekhar, occupational Therapist

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I do not use non-FDA approved uses for drug products

Eileen Elias, MEd

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Andrew Elkwood, MD, FACS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Lisa Engel, MSc OS/OT, BKin

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Karen D Ethans, MD, FRCPC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Christopher Evans, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Nicholas Evans, MHS, ACSM-CES

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Michael Fehlings, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Melissa Marie Felteau, MAdEd

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Robert J. Ferguson, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Geoff Fernie, PhD, PEng, FCAHS

Participant discloses the following relationships:

1. TRI-University Health Network: All 3 authors stand to gain personally from commercialization of their

inventions under the IP policy of TRI-University Health Network

Participant has indicated the following discussion of unapproved drug or product uses:

Yes

Dr. Edelle C. Field-Fote, PhD, PT, FAPTA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

rTMS and tDCS are approved for uses on peripheral nerves, however I will disclose that rules for their use for

transcranial stimulation depends on state practice acts

Professor Marcia Finlayson, PhD, OT Reg (Ont), OTR

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Nadine M Fisher, Ed.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr John Francis Flannery, FRCPC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Heather Margaret Flett, M.Sc, BScPT, BA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Donald Fogelberg, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Stephanie Foo, MPH

Disclosure has not been provided.

Dr. Mary Forhan, O.T.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gail F. Forrest, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Shari Frankel, MBA, PT, ATC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jennifer French, MBA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Janna Friedly, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jack Brian Fu, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Robert Fucetola, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Andrea D Furlan, MD., PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Opioids are generally approved to manage moderate to severe pain. We will discuss the use of opioids for

management of weak, moderate and severe pain.

Denise Fyffe, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Elizabeth Gaffron, MOTR/L, LMT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Cynthia Gagnon, OT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Dany H Gagnon, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Isabelle Gagnon, MSc, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Rolf B. Gainer, PhD

Participant discloses the following relationships:

1. Rehabilitation Institutes of America and related companies: Employee, Board Member, stockholder

Participant has indicated no discussion of unapproved drug or product uses.

Dr Ann Gamsa, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Caron Gan, RN, MScN, RMFT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Keith Ganci, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Julie Gassaway, RN MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Lynne Gauthier, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Joseph Giacino, PhD, FACRM

Participant discloses the following relationships:

1. James S. McDonnell Foundation: Site PI on grant funded by private fdn

2. The Barbara Epstein Foundation, Inc: Recipient of donation

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Lora Giangregorio, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Chelsia Gillis, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Stephanie Gilmore, PT,DPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Clare Giuffrida, PhD, OTR/L, FAOTA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mel B Glenn, M.D.

Participant discloses the following relationships:

1. Judith Ashway, LICSW, (my wife) psychotherapy private practice : self-employment

Participant has indicated the following discussion of unapproved drug or product uses:

methylphenidate, amphetamines, amantadine, donepezil, atamoxetine, modafinil, armodafinil

Heather Glubo, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Yelena Goldin, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ashraf S. Gorgey, PT, PhD, FACSM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Yael Goverover, PhD, OT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Erik Grauwmeijer, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. William B. Gray, D.O.

Disclosure has not been provided.

Dr Robin E.A. Green, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dayna Greenspoon, B.Sc (hons), MScOT, OT Reg.(Ont)

Participant discloses the following relationships:

1. This research project (examining the KOSCHI) is funded by the Physicians' Services Incorporated: Research

Grant

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Brian David Greenwald, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Alisa Grigorovich, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sivakumar Gulasingam, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Yelena Guller

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Halina Lin Haag, MSW, RSW

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Julie Haarbauer-Krupa, PhD

Participant discloses the following relationships:

1. National Institute on Disability and Rehabilitation Research through Children's Healthcare: Principal Investigator,

Salary Support through Children's Healthcare of Atlanta

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Juliet Haarbauer-Krupa, PhD

Participant discloses the following relationships:

1. National Institute on Disability and Rehabilitation Research: Salary Support as Principal Investigator on a Grant

Award (through Children's Healthcare of Atlanta

Participant has indicated no discussion of unapproved drug or product uses.

Olinda Habib Perez

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Joy Hammel, PhD, OTR

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Flora Hammond, MD

Participant discloses the following relationships:

1. Avanir: Prism II Steering Committee member

Participant has indicated the following discussion of unapproved drug or product uses:

I will be discussing medications used during inpatient TBI.

Ms EUN YOUNG HAN

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Y

Dr. Kihwan Han, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Kelly Hanna

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

MR. Wouter Harmsen

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Eric Harness, CSCS

Participant discloses the following relationships:

1. Project Walk: Co-Founder, Employee

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jocelyn Harris, OT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Tessa Hart, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Clare Hartigan, PT, MPT

Participant discloses the following relationships:

1. Parker Hannifin Corporation PHC): PHC is the manufacturer of Indego and has supported some of the Indego

research conducted at Shepherd Center. Shepherd Center is a clinical partner with PHC

Participant has indicated the following discussion of unapproved drug or product uses:

The Indego Exoskeleton is being used for clinical research trials only. The device has not yet been FDA

approved for general use.

Sharon Hartl, BS, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr David T Harvey, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Ali Hassan, MScPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Magdy Hassouna, MD PhD FRCSC FACS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dawn Hatanaka, BA (Hons)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Hanne Haugland, R.N.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Brent L Hawkins, LRT/CTRS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Amy Hayman

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Allen Heinemann, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Douglas Henry, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Amy A Herrold, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Patricia Cristine Heyn, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Audrey Hicks, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Gregory Hicks, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Elizabeth Hile, PhD, PT, NCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Valerie Ann Hill, PhD, MS, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Cesar Hincapie, DC, MHSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

MRS Tânia Lúcia Hirochi, OT, M.Sc.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Mark A. Hirsch, PhD

Disclosure has not been provided.

Dr. Asai Hitoshi

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sander Hitzig, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Chester Ho, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Helen Hoenig, MD, MPH, OT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jeanne M Hoffman, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. John Hollman, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Roee Holtzer, PHD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

We do not use any unlabeled/unapproved drugs in our research. We will report on the use of fNIR technology.

Minna Hong

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gordon J. Horn, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Susan D Horn, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Gillian Hotz, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Pamela Houghton, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Kevin Edward Houston, O.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Amy Houtrow, MD, PhD, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jo-Anne Howe, PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Kimberly P. Hreha, MS, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Pei-Chi Hsiao, M.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mei-Chi Hsieh, student

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Ya-Fang Hsu, O.T.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ryan Hung, M.D, MSc.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I will discuss use of medications for sleep disorders in children that are commonly used in practice in North

America; however, some of these medications do not have FDA approval for use in children.

Ms. Eileen Hunsaker, MS. CCC-SLP, CBIS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Anne Williams Hunt, PhD, OT Reg (Ont)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Cindy Hunt, Dr.PH. RN

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Michael G Hutchison, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Ai-Wen Hwang

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Brian Im, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Ingebjorg irgens, M.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Hiroshi Irisawa, M.D., Ph.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Farooq Ismail, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Tiffani Jantz, M.S.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Alicia M. January, PhD

Participant discloses the following relationships:

1. Shriners Hospitals for Children: Research Support

2. National Institute on Disability and Rehabilitation Research (NIDRR): Research Support

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Arun Jayaraman, PT PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Chris Jensen, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Patricia Charlotte Johnson, Ph.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Therese E Johnston, PT, PhD, MBA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Michael Jones, PhD, FACRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Shannon B Juengst, CRC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Se Hee Jung, M.D., Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Alexander C. Jungreis, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Corinne Kagan, BA. Hons, BPS Cert.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Maria Kajankova, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sukhvinder Kalsi-Ryan, BScPT MSc PhD

Participant discloses the following relationships:

1.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Aziza Azadali Kamani, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Casey Kandilakis, PT, DPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Lin-ju Kang

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Naaz Kapadia

Participant discloses the following relationships:

1. Toronto Rehabilitation Institute -UHN: employee

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Amol M Karmarkar, PhD, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Fumihito Kasai

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Tricia Kasamatsu, M.A., ATC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Douglas I Katz, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Nicola Maree Kayes

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jacob Kean, PhD, CCC-SLP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Michelle Keightley, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Tetyana Kendzerska, MD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ashleigh Cruise Kennedy

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Bonnie L Kennedy, OTR/L

Participant discloses the following relationships:

1. Blue Marble Game Co.: Employee

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mary Alunkal Khetani, Sc.D., OTR

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Grace J Kim, OTR

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. So-yeon Kim, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sonya Kim, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Akira Kimura, Ph.D,RPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Omuron-HSL101

Jeffrey A Kleim, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sasha E Knowlton, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. RYO KONDO

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Cyndie Koning, PhD, OT (C)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Pia Kontos, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Allan John Kozlowski, PhD, B.Sc (PT)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Anna Kratz, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Denise Krch, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Hermano Igo Krebs, Ph.D.

Participant discloses the following relationships:

1. Interactive Motion Technologies: Board of Directors, Equity Holder

2. Intuitive Surgical: Royalties

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Vicki Leigh Kristman, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lauren Krupp, MD

Participant discloses the following relationships:

1. Novartis Pharmaceutical: Consultant (Advisory Board); investigator-initiated research support

2. Teva Neurosciences: Consultant; investigator-initiated research support

3. Biogen Idec : Consultant (Advisory Board); investigator-initiated research support

4. EMD Serono: Consultant

5. Genentech: Clinical trial research support

6. Celgene Corporation: Clinical trial research support

7. Garnett McKeen Laboratory Incorporated: Investigator-initiated research support

Participant has indicated no discussion of unapproved drug or product uses.

Amy Kuceyeski, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Kshitija Kulkarni, MS OTR/L

Disclosure has not been provided.

Dr Dinesh Arun Kumbhare, M.D., M.Sc.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Bravina Kuni, M.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Brad Kurowski, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. David S. Kushner, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sarah Lahey, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Eric M Lamberg, EdD, PT, CPed

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Marie-Eve Lamontagne, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Marie-Eve Lamontagne, O.T.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jeanne Langan

Disclosure has not been provided.

Mrs Marie-Therese Laramee, MSc(pht)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Nancy Latham, PhD PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Amy Latimer-Cheung, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Hannah P. Leahy, D.O.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Nathan K. LeBrasseur, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

John Leddy, MD, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Hee Song Lee

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Yes, I intend to reference unlabeled/unapproved uses of drugs or products in my presentation and I agree to

disclose this information to the audience as required by accreditation guidelines

Hee Song Lee, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sabrina Lee, Ph.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Seok Tae Lee

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Natalie E Leland, PhD, OTR/L, BCG, FAOTA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

dr Carolyn Marla Lemsky, Ph.D.,C.Psych.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Isabelle Lessard, PT

Disclosure has not been provided.

Dr William Mark Magnus Levack, PhD MHealSc(Rehabilitation) BPht

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Charles Edward Levy, M.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Frank David Lewis, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Yue Li

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Associate Profes Hua-Fang Liao, Physical Therapist

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. alexander libin, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Wen-Chih Lin

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Påvel Lindberg, PT, PhD

Participant discloses the following relationships:

1. AggeroMedtech company in Sweden: Shareholder

Participant has indicated no discussion of unapproved drug or product uses.

Dr Raquel Rodrigues Lindquist, PT, PhD, FACSM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Beth Linkewich

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Tsan-Hon Liou, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Christy Littaua, M.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

off label uses of medications to aid in concussion recovery and symptom management.

Dr. Eldon Loh, MD, FRCPC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Miss Coralynn Long, M.S.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Catherine Lowrey

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Adalberto Loyola-Sanchez, M.D, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. William Lu, PsyD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Barbara Lutz, PhD, RN, CRRN, APHN-BC, FAHA, FA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Kathleen Lyons, ScD, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Kaitlin MacDonald, MOT, OTR/L

Disclosure has not been provided.

Chris MacDonell

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sangeetha Madhavan, PT PhD

Disclosure has not been provided.

Susan Magasi, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Katie Mah, BScN, MScOT, OT Reg(Ont)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jeannette R Mahoney, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

We do not use unlabeled/unapproved drugs or products in our research

Dr Lynda Mainwaring, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Michael Joseph Makley, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. James F Malec, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Trudy Mallinson

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Gabriela Markovic, neuropsychologist

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Connie Marras, M.D., Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Stephanie Marrocco

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Shawn Marshall, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Juan David Martina, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. David Martinez, B.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sharon Ann Martino, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Andrea Mastrogiovanni, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Yuliya Maystrovskaya, DO

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Keith Mc Bride, MPT, DPT

Participant discloses the following relationships:

1. Bioness: Employee of Bioness Inc; a developer, manufacturer and distributor of rehabilitation technology.

Participant has indicated no discussion of unapproved drug or product uses.

Karen McAvoy, PsyD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Karen Leigh McCulloch, PT, PhD, NCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Kevin McCully, PhD

Participant discloses the following relationships:

1. NIH: Grantee

2. Biogen: Grantee

3. Novartis: Grantee

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Janette McDougall, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Tara L McIsaac, Ph.D, P.T.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

William Barry McKay, Research Scientist

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Raymond McKenna, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Brian McMichael, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Professor Kathryn M McPherson, RN, RM, BA(Hons), PhD, FAFRM(Hon

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jennifer McWain

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Swati Mehta

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Anthony Melchiorre, PsyD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr TÂNIA MARIA DA SILVA MENDONÇA, II, PHD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jose F Meneses-Echávez, PT, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Hannah Warner Mercier, MS, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Peter Meulenbroek, Ph.D., CCC-SLP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Susan Miale, PT, DPT, PCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Alex Mihailidis, Ph.D. P.Eng.

Participant discloses the following relationships:

1. TRI-University Health Network: All 3 authors stand to gain personally from commercialization of their

inventions under the IP policy of TRI-University Health Network

Participant has indicated the following discussion of unapproved drug or product uses:

Yes

Dr. Eva G. Mihovich, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Maria C Milazzo, RN, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Elaine Tilka Miller, PhD, RN, CRRN, FAAN, FAHA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jacqueline Mix, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sambit Mohapatra, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Tatyana Mollayeva, MD, PhD (cand)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ryo Momosaki, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Diane Florence Morean, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Peter J. Morelli, MD

Disclosure has not been provided.

Mr Jhon Alexander Moreno, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jacqui H Morris, MCSP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jeri Morris, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

John Morris, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Cindi Morshead, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Rosemarie Scolaro Moser, Ph.D., PhD, ABN,ABPP-RP

Participant discloses the following relationships:

1. I own and direct the Sports Concussion Center of New Jersey, as a private practice. I also am author of a

concussion book.: self

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Andrea Mothe, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Suzie Mudge, PhD

Participant discloses the following relationships:

1. Waitemata District Health Board (WDHB): I am the recepient of a Post Doctoral Research Fellowship from

WDHB

Participant has indicated no discussion of unapproved drug or product uses.

Laura Mumme, BSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Lisa M Muratori, PT, EdD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Sarah Murdoch, PT, DPT

Disclosure has not been provided.

Kelly Murphy, PhD, CPsych

Participant discloses the following relationships:

1. Learning the Ropes is a commercially available program: I hold IP in the above mentioned program and am

eligible to receive royalties

Participant has indicated no discussion of unapproved drug or product uses.

Ms Judy Murray, MScPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Rachel Müller, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Masaaki Nagashima

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Drew A Nagele, PsyD, CBIST

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Risa Nakase-Richardson, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Emily Joan Nalder, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mark S. Nash, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Abdullah Nasif, M.S

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dawn Neumann, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Holly DeMark Neumann, MPPA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Robin M. Newman, OTD, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Zhi Min Ng, MBBS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Vu Nguyen, M.D.

Participant discloses the following relationships:

1. NDI Medical: Research grant

2. Allergan: Research grant

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Lian Ni, Master

Disclosure has not been provided.

Dr. Janet P. Niemeier, PhD, ABPP (RP)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Paulette Niewczyk, MPH, PhD

Participant discloses the following relationships:

1. UDSMR: employee

Participant has indicated no discussion of unapproved drug or product uses.

Corien Nikamp, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Anne Teresa O'Brien, PT, NCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Michael O'Dell, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Alexandra E. A. Oatley, PhD (Candidate)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Hilda Alcântara Veiga de Oliveira, Pt

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Y

Dr. Lisandro Olmos, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Miss Courtney S Ostrega

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Kenneth Ottenbacher, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Bert Oucharek

Disclosure has not been provided.

Dr. Donna Ouchterlony, MD, CCFP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Marie-Christine Ouellet, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Lora Packel, PhD, MSPT, CCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Stephen Page, PhD, OTR\L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Melissa Paniccia, OT Reg. (Ont.)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms Christina Papadimitriou, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Theresa Pape, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Transcranial Magnetic Stimulation with TBI

Monique Renae Pappadis

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Poonam Pardasaney, DPT, MS, ScD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jan Park Dorsay, RN(EC), MN, CON(C), RMFT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

William Parkinson, PhD

Disclosure has not been provided.

Dr. Kara Kathleen Patterson, PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. James Pau

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Lorraine (Lori) Joyce Pearl-Kraus, PhD, CS, FNP-BC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Matthew Jason Pelcowitz, B.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

I do.

Jaclyn Peters

Disclosure has not been provided.

Elizabeth Peterson, PhD, OTR/L, FAOTA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Chetan P. Phadke, BPhT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Treven Curtis Pickett, PsyD, ABPP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Linda Pierce, PhD RN

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Rakesh Pilkar, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Milos R. Popovic, PhD

Participant discloses the following relationships:

1. TRI-University Health Network: All 3 authors stand to gain personally from commercialization of their

inventions under the IP policy of TRI-University Health Network

Participant has indicated the following discussion of unapproved drug or product uses:

Yes

Dr. Jose Posas, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Marcel WM Post, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Valérie Poulin, OT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Janet M. Powell, PhD, OTR/L, FAOTA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Christopher R. Pretz, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Rachel Proffitt, OTD, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Miss Polina Provad, BSc Hon. Kin, MSc PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Wenchun Qu, MD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jason Raad, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mary Vining Radomski, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Prathap Raghavan, MD, FRCPC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Vishwa Raj, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Jelena Rakic, B.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Sharon Ramey

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Robinson Ramírez-Vélez, P.T, Ph.D

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Kirk Randall

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Joseph F. Rath, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Andrew D Ray, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Kateri Raymond, O.T.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Nick Reed, PhD OT Reg (Ont)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Ronald K Reeves, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Paula Reguly, BSc, MPH

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Bertjo Renzenbrink, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Linda J Resnik, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Tatiana Souza Ribeiro, PT, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Danielle Brittany Rice, B.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Marina Richardson

Disclosure has not been provided.

Prof. Dr. Johan S. Rietman, MD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Richard Riggs, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Pamela Roberts, PhD, OTR/L, SCFES, FAOTA, CPHQ

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Susan Robinson-Whelen, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Moyra Rondon, LCSW

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sharmella Carol Roopchand-Martin, DPT, MSc. Rehab. Sci.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Not using any drug in the study but videogame was used in the research

Dr. Emily Rosario, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Amy Rosenbaum, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Peter Rumney, MD, FRCPC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Ju Seok Ryu, M.D., professor

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof Cath Sackley, MCSP MSc PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Mahsa Sadeghi, M.D

Disclosure has not been provided.

Dr Cherian Sajan, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mohammed Sakel

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

agreed.

Anna-Liisa Salminen

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Angelle M. Sander, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Daniel Santa Mina, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Elizabeth Sasso, PT, DPT, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lee Saunders

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Mohamad Sawan, P.Eng., Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Isobel Ann Scarisbrick, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Lutz Schega, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Brent Schiller

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Arlene A. Schmid, PhD, OTR

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Kenley Schmidt, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Mary Schmidt-Read, PT, DPT, MS

Disclosure has not been provided.

Dr. caroline schnakers, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Joel Scholten, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Brian William Schulz, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Carol Scovil, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jill Seale, PT, PhD, NCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ronald Seel, PhD, FACRM

Participant discloses the following relationships:

1. Pearson Publishing: Royalty received for sales on the Neurobehavioral Functioning Inventory

Participant has indicated the following discussion of unapproved drug or product uses:

We will discuss if some meds impact effort in inpatient rehabilitation, I will not use the brand names of any

drugs discussed and will include a slide noting that there are currently no FDA approved drugs for the treatment

of TBI

Neil Segal, MD, MS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Peter Selby, M.D.

Participant discloses the following relationships:

1. AbbVie: Paid consultant and educator in motivational interviewing

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Arrani Senthinathan, MSc.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Dahlia M. Shaewitz, M.A.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Colin M Shapiro, M, FRCPC, MBBS, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Arya Sharma, MD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Vivek Sharma, MPT(Neuro)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jay Shaw, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Miss Heather Allison Shepherd

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mark Sherer, ABPP, FACRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Sue Sherratt, BA, GCTT, BA (Speech Pathology a

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Ki Y Shin, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Zahra Shirzadi

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Hilary Siebens, MD

Participant discloses the following relationships:

1. Siebens Patient Care Communications: sole source consulting practice

Participant has indicated no discussion of unapproved drug or product uses.

Professor Richard John Siegert, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Julie K Silver, MD

Participant discloses the following relationships:

1. Oncology Rehab Partners, LLC: Co-Founder

2. Ella Health: Board Member

Participant has indicated no discussion of unapproved drug or product uses.

Noah Silverberg

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Richa Sinha

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Marie-Josée Sirois

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Jason-Flor Villarosa Sisante, M.S.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sue Ann Sisto, PT, MA, PhD, FACRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Amanda Smart, PT, MSc. PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lucia Smith-Wex;er, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

none

Dr. Deborah Snell, None

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Kaitlyn Snell

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Jacob Sosnoff, PhD

Participant discloses the following relationships:

1. Concert Pharmaceuticals: Consultant

2. National Multiple Sclerosis Society: Grant Funding

3. Consortium of MS Centers : Grant Funding

4. NIH: Grant Funding

Participant has indicated no discussion of unapproved drug or product uses.

Dr Ligia Sousa

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Ana Paula Spaniol, Physical Therapy Student

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs. Kerstin Spielmann

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mary Squillace, DOT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Sudarshan Srivatsan, B.S.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Ibuprofen was used to enhance lower motor function

Dr. Vess Stamenova

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Steven Stanos, DO

Participant discloses the following relationships:

1. Collegium, Mallinckrodt, MyMatrixx, Pfizer, Zogenix: consultant

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Mary Stergiou-Kita, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Nicole L Stout, DPT

Participant discloses the following relationships:

1. Zansors LLC: SME Consultant

2. OnQHealth: SME consultant

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Derek William Stouth

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Robert Streb

Participant discloses the following relationships:

1. Townsend: funded independent research project

Participant has indicated no discussion of unapproved drug or product uses.

Donald T Stuss, PhD, CPsych, ABPP-CN, Order of O

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Daniel Chiung Jui Su, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Patria Surerus, MA

Participant discloses the following relationships:

1. Neurologic Rehabilitation Institute of Ontario: Employee

Participant has indicated no discussion of unapproved drug or product uses.

Stacy Suskauer, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Christopher Szybbo

Participant discloses the following relationships:

1. CBI Health Group: owner/ shareholder

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Hilde Sørli, P.T

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr Takashi Takebayashi

Participant discloses the following relationships:

1. Teijin Pharma Ltd. (Tokyo, Japan) : Author completed an advisory contract worth 10000 dollars with Teijin

Pharma Ltd. (Tokyo, Japan) on the development of robotics for arm rehabilitation last year.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Ada Tang, PT PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Heather Taylor

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Robert William Teasell, MD FRCPC

Participant discloses the following relationships:

1. Allergan: Grant funding

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Candy Tefertiller, PT, DPT, ATP, NCS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Martin Tenniglo, PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Srinivas Teppala, M.B.B.S., M.P.H.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Carmen militza Terzic, MD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Spencer Richard Thompson, BSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Christine Till, PhD, C.Psych

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Misti Timpson, DPT, NCS, CBIS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Jennifer C Tomaszczyk, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Kounosuke Tomori

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Julia Totosy de Zepetnek, PhD (c)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

No unlabeled/unapproved drugs were used in this study.

Dr. Angela K. Troyer, PhD, CPsych

Participant discloses the following relationships:

1. Memory and Aging Program materials: Author and IP holder, eligible for royalties on sales

Participant has indicated no discussion of unapproved drug or product uses.

Catherine Truchon, PhD, MscAdm

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

no unlabeled/unapproved uses of drugs involved

Mr. Daniel C. Tufaro, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. James Yungjen Tung, PhD, PEng

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ms. Josie Turbach, HBA

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gary R Ulicny, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Marieke Van Puymbroeck, Ph.D., CTRS

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr William Christian VandenBerg, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Leslie VanHiel, PT, DScPT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Armando J Vasquez Barrios, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Stephanie Ann Vaughn, PhD RN CRRN

Participant discloses the following relationships:

1. Hollister, Inc.: education consultant

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Diana Velikonja, PhD, CPsych

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Joe Verghese, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

We do not use unlabeled/unapproved drugs in our research

Mr. Lee Verweel

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Y

Marieke M Visser, MSc

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Not applicable.

Mr. Per Maximilian von Groote

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Hubert Vuagnat, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Shinichi Wada, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Joanne M Wagner, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

William C. Walker, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Sarah Wallace, PhD, CCC-SLP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mr. Chia Cheng Wang, PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Michael S Weinstein, MD, MRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Pey-Shan Wen, OTR

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jennifer V Wethe, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jane L. Wetzel, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Gale Whiteneck, PhD, FACRM

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. John Whyte, MD, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Mrs Sandra Maria Wielaert, MPHil, SLP

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Matt Wilks, MS, PT

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Barry Willer, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Vernon Williams, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jan-Paul van Wingerden, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Brooks C Wingo, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Catherine Wiseman-Hakes, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Catherine Wiseman-Hakes, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Eric Wisotzky, M.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

botulinum toxin for postmastectomy pain

Dr. Virgil Wittmer, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Dalton Wolfe, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Alex Wong, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Christopher Kevin Wong, PT, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Sarah Woodworth, MOT, OTR/L

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Lise Worthen-Chaudhari, MFA, MS, CCRC

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Virginia Wright, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Prof. Ching-Yi Wu, ScD, OTR

Disclosure has not been provided.

Dr. Eun Joo Yang, M.D., PhD.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ceren Yarar-Fisher

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. E. Ann Yeh, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated the following discussion of unapproved drug or product uses:

Medications that may be discussed will include modafinil and amantadine in fatigue in Pediatric MS. I will

disclose this in my presentation if I discuss these drugs.

Chia-Feng Yen

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Angela Yi

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Paul B Yoo, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

James M. Young, MD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Ross Zafonte, DO

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr. Jose Zariffa, Ph.D.

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Nathan Zasler, MD, FAAPM&R, FAADEP, DAAPM, CBIS

Participant discloses the following relationships:

1. Concussion Care Centre of Virginia, LTD: CEO

2. Tree of Life Services, Inc.: CEO

Participant has indicated the following discussion of unapproved drug or product uses:

drugs for post-traumatic headache management

Mr Dominik Zbogar

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Bart Zegers

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

Dr Kristin D. Zhao, PhD

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.

MRS Irene Øyeflaten, PhD (candidate)

Participant has no financial or non-financial relationships to disclose.

Participant has indicated no discussion of unapproved drug or product uses.